In the wake of the COVID-19 epidemic, medical facilities and drugs are in high demand. Even in India, the world’s second most populous nation, incidences of Covid-19 are on the rise. As it expands and provides the required facilities, the Indian pharmaceutical industry is also transforming lives. Indian pharmaceutical businesses made 18.12 billion USD in 2018 and 19.14 billion USD in the fiscal year 2019, according to the Ministry of Chemicals & Fertilizers. Drug sales in the United States totaled 2.15 billion dollars in the month of April, 2021. It has grown by 51.5 percent from April 2020, when it was only $1.42 billion. Annual turnover has risen from $19.64 billion in April 2020 to $20.88 billion in April 2021
India is the world’s biggest supplier of generic medications, with its top pharma businesses accounting for 20 percent of worldwide exports. It is predicted that by 2023, India’s pharmaceutical industry would be valued 33.18 billion USD, making it the ninth-largest in the world. We’ve compiled a list of some of India’s most prominent pharmaceutical businesses here.
Top Pharmaceutical Companies of India
- Sun Pharmaceutical Industries
- Divi’s Laboratories
- Reddy’s Laboratories
- Cipla Limited
- Biocon Limited
- Torrent Pharma
- Lupin Limited
- Cadila Healthcare Limited
- Aurobindo Pharma Limited
- Intas Pharmaceuticals Limited
- Glenmark Pharma Limited
- Innovexia Life Sciences Pvt. Ltd.
- Biophar Lifesciences Pvt.Ltd.
- Mankind Pharma Limited
- Piramal Enterprises Limited
- Laurus Labs Ltd.
- Abbott India Ltd.
- Alkem Laboratories
- Alembic Pharmaceuticals
